Clarification21 Sept 2026, 12:00 pm
Senores Pharmaceuticals Clarifies Volume Movement
AI Summary
Senores Pharmaceuticals Ltd has responded to a stock exchange query regarding unusual volume movements in its scrip. The company stated that it is in compliance with SEBI (LODR) Regulations and has promptly informed the exchanges of all material information. Senores Pharmaceuticals confirmed that there is no undisclosed price-sensitive information or any impending announcement or corporate action that needs to be disclosed at this time. They assured continued compliance with disclosure regulations.
Key Highlights
- Company clarifies scrip volume movement as per exchange request.
- No undisclosed price-sensitive information exists.
- No impending announcements or corporate actions.
- Company assures ongoing compliance with SEBI regulations.
Price Impact
More from SENORES